Ferrer, Poirot & Wansbrough | Injury Law Blog
March 24th, 2015
Drug manufacturer GlaxoSmithKline released Zofran®, a powerful anti-nausea drug, several years ago as for use in patients undergoing chemotherapy. The drug soon began to be marketed off label to treat pregnant women suffering from morning sickness. Since that time, it has come to light that taking Zofran can cause unborn children of pregnant mothers to be born with birth defects.
One of the most common Zofran birth defects are heart defects, which can have lifelong health effects and require corrective surgery.
An article from KVLY 11 News tells the story of a two-year-old girl born with heart problems after her mother took Zofran during pregnancy. The condition wasn’t discovered until recently when the child underwent an X-ray. Now, the child must undergo open-heart surgery to close two holes in her heart.
A benefit is being held to help raise funds for the child’s medical costs, but the drug injury attorneys with Ferrer, Poirot, & Wansbrough explain that familes of Zofran birth defect victims may also be eligible for compensation.
Filing a drug injury lawsuit can be complicated, which is why we suggest speaking with an attorney about your case as soon as possible. Doing so can help ensure your legal rights to compensation are protected throughout the legal process.
March 17th, 2015
Testosterone is a male hormone that assists in the regulation of body mass, mood, energy level, and sex drive. As men age, their bodies produce less of this hormone, which can result in changes affecting a variety of body systems.
Some medical professionals have developed treatments for decreased testosterone levels known as low testosterone (Low T) therapy. For many, this seems like a wonderful solution to their problems, but the U.S. Food and Drug Administration (FDA) recently issued a warning regarding Low T therapy health risks.
Officials say that the use of testosterone products or undergoing Low T therapy could put patients at risk of suffering a heart attack or stroke. The FDA is also requiring changes in the labeling of drugs being used in testosterone therapy to carry warnings about Low T therapy heart attack risks.
The warnings go on to instruct patients to consult their physicians immediately if they experience any signs of a heart attack, including shortness of breath or chest pain. Anyone who suffers adverse health events associated with Low T therapy should also report the incident to the FDA immediately.
At Ferrer, Poirot & Wansbrough, our team of drug injury lawyers has advocated for numerous patients harmed by drugs and medical devices, and we are here to help if you’ve suffered a testosterone therapy injury. We’re available to answer your questions—just dial (866) 589-0257.
March 10th, 2015
Reports indicate that the use of the drug Xarelto® to prevent blood clots from developing in the body can lead to uncontrollable bleeding which, in turn, has led to hundreds of Xarelto injury lawsuits being filed in federal courts.
To help relieve the increasing volume of the court’s caseload, many Xarelto injury lawsuits were consolidated in multidistrict litigation (MDL). This places special rules and regulations on the cases that help ensure the cases move efficiently through the system.
One of the first steps of beginning the MDL is the creation of a Plaintiff’s Steering Committee, and Ferrer, Poirot & Wansbrough is proud to announce that one of our own attorneys, Russ Abney, has been appointed to the Plaintiff’s Steering Committee for the Xarelto MDL in Louisiana.
Russ’ responsibilities as a member of the committee will include initiating, planning, and conducting numerous aspects of pretrial discovery, as well as coordinating and managing issues during hearings, meetings, and bellwether trials pertaining to the case.
Only 12 attorneys, including two leading co-counsels, were selected to join the committee.
At Ferrer, Poirot & Wansbrough, we’re proud of each and every accomplishment made by our team members. That’s why we would like to congratulate Russ Abney on his appointment and wish him the best in this very important role.
February 24th, 2015
For those at risk of life-threatening blood clots, an inferior vena cava (IVC) filter can be an effective treatment. However, these medical devices may put users at serious risk of suffering IVC filter injuries.
An IVC filters is a small medical device inserted into a patient’s veins to prevent blood clots from traveling into the lungs. The devices have been found to be prone to breakage and failure though, allowing them to migrate through the body causing serious harm. IVC filter injury reports range from pain in the chest to organ perforation—and even death.
Many who have suffered IVC Filter injuries have filed lawsuits against the maker of the product. In fact, a settlement was recently reached in one of these cases.
According to the website lawyersandsettlements.com, a Nevada man was recently awarded an undisclosed amount in damages for IVC filter injuries. The lawsuit claimed the patient did not receive proper warnings regarding the device’s dangers. The claims were supported by several studies that showed the dangers of using an IVC filter.
At Ferrer, Poirot & Wansbrough, we recognize the know the harm that can be caused by defective medical products, and our attorneys are hopeful this recent settlement brings a sense of closure to the patient who was harmed.
February 17th, 2015
When the Stryker metal-on-metal hip replacement came on to the market, it was expected to offer patients a long-term and lasting solution to their hip problems. However, the device failed in many cases, leaving patients in pain and in need of corrective surgery.
In response, many of the patients who experienced hip failure or painful side effects filed hip recall lawsuits to get compensation for the damages they suffered. Bloomberg Business reports a settlement was reached in Nov. 2014 that established a more than $billion trust to be used to pay restitution to patients who experienced complications with their Stryker hip devices. This means each patient could receive more than $300,000 in compensation.
Those who filed hip recall lawsuits aren’t the only ones who may qualify for compensation, though. A stipulation in the settlement says that anyone who underwent surgery to correct problems caused by the Stryker device prior to the settlement date are eligible to file for compensation. Anyone who underwent a corrective procedure after the settlement date may not qualify for compensation through this particular lawsuit but are still entitled to file a lawsuit of their own.
The defective medical device lawyers at Ferrer, Poirot & Wansbrough understand the difference this compensation can make in the lives of patients harmed by Stryker hip replacement devices. We are hopeful the settlement will help bring closure to the pain and suffering these individuals have endured over the years.
February 10th, 2015
Antibiotics are often an essential part of treating the illnesses and infections, but it’s important to remember these drugs can cause some people serious harm. In fact, a recent report cited a number of individuals who suffered negative antibiotic side effects after taking a drug called levofloxacin.
WSB-TV 2 News reported a man died after taking only two doses of the drug. He reportedly suffered pain and high fever shortly after taking the first dose and was admitted to the hospital shortly before expiring. An autopsy found he died as a result of rhabdomyolysis, a disease that destroys muscle tissue.
Rhabdomyolysis has been linked to taking levofloxacin, yet safety warnings were not added to the drug packaging until after it was released to the public. Since then, patients have come forward saying they have experienced this side effect as a result of taking levofloxacin.
The U.S. Food and Drug Administration (FDA) is now conducting more research to determine if more stringent warnings are needed for the product.
At Ferrer, Poirot & Wansbrough, we’ve seen the serious harm antibiotic side effects can have on patients. That’s why our drug injury lawyers are hopeful action is taken to prevent any other patients from harm.
February 3rd, 2015
Each year, a large number of Americans suffer drug injuries as a result of taking medications prescribed by their doctors. The U.S. Food and Drug Administration (FDA) is in charge of recording the incidents and developing plans of action to address dangerous drugs. However, a new study has found that reporting system may be heavily flawed.
An article from The Wall Street Journal explains that while the FDA Adverse Event Reporting System (FARS) allows anyone to file a report of a drug injury or defective medical device, drug manufacturers report 97 percent of incidents. Unfortunately, these reports are often lacking vital information that could prevent further injuries, such as dates and patients’ ages.
Additionally, changes in regulations governing the marketing of medical devices and drugs have occurred since the reporting system was last updated. This can also result in a lack of vital information in adverse event reports.
So what is being done to correct these issues? The FDA has launched it’s Sentinel Initiative to monitor drug safety, and the program is now ramping up.
The drug injury lawyers with Ferrer, Poirot & Wansbrough are aware of the dangers a drug injury can pose to a patient. That’s why we’re hopeful that the FDA is successful in improving the way drug and defective medical device injuries are reported.
January 27th, 2015
A new report shows that certain manufacturers may be more likely to recall drugs and defective medical devices. One such company is Hospira. The manufacturer of both medications and medical devices are said to have initiated as many as 40 recalls in the last two and a half years due to problems found in their products.
According to In-PharmaTechnologist,com, the U.S. Food and Drug Administration (FDA) points out that last year, 45 class I recalls were conducted by drug makers. Of those, almost one-third involved medications made by Hospira. Those aren’t the company’s only recalls, though.
In 2012, Hospira conducted 28 drug recalls, while an additional 11 recalls were initiated for a defective medical device manufactured by the company. Several of the company’s manufacturing facilities were given warning letters by the FDA.
The company’s most recent recall involved an injectable version of sodium chloride that was contaminated by human hair before being distributed to the public.
At Ferrer, Poirot & Wansborugh, we have seen the harm that caused by using unsafe drugs and defective medical devices. That’s why our defective medical device lawyers suggest checking the FDA’s website frequently to ensure your medical products have not been recalled recently.
January 20th, 2015
Advancements in technology have helped Americans live healthy lives, but developments in medical and health devices have raised several questions about the preventing defective medical products from reaching consumers.
Most of us concede the importance of regulations placed on items like insulin pumps or dialysis machines, but what about heart monitors people wear on their wrists while working out? Should over-the-counter gadgets be required to face the same regulations? Officials from the federal government say the answer to that question is yes.
According to Engadget, the U.S. Food and Drug Administration (FDA) is calling for public opinion on a set of rules to guide the design, manufacturing, and distribution of what’s being described as “general wellness devices.” These regulations will be placed on any device that claims to make improvements to a person’s health.
The problem is, the lines are very murky between claims to improving wellness and the treatment of medical conditions. That’s why the FDA is expected to make several changes to the drafted rules before a vote on the initiative is taken.
At Ferrer, Poirot & Wansbrough, we see the results of faulty products on a daily basis. Our defective medical device lawyers are anxious to see if these new regulations are put into place.
January 13th, 2015
As men become older, they can lose energy, body mass, and even their sex drive. Hormone replacement therapies have come onto the market in recent years, but it’s important that American men understand that certain versions of these products can present very serious health risks.
One of the more common hazards being reported today is a testosterone therapy heart attack. Men who have used products like Androgel® and Axiron® have reported suffering heart attacks and other cardiovascular conditions at a much higher rate than those who didn’t use the products.
According to Reuters, the U.S. Food and Drug Administration is also seeking additional data on the safety of another testosterone replacement product, known as QuickShot Testosterone. The study, which could take up to a year to complete, was requested after a patient using the drug had an allergic reaction to the product. Symptoms included hives, itching, and bumps on the skin.
While warnings about the dangers of testosterone replacement products are important, the cautions come too late for many. That’s why it’s important for those who are harmed as the result of using such a product know that help is available.
At Ferrer, Poirot & Wansbrough, our drug injury lawyers have helped thousands of drug injury victims, and we want to do the same for you. Call us 24/7 at (866) 589-0257 for a free case consultation.